Rentokil Initial plc (RTO)

CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,552	12,602	14,053	15,367	14,642	12,848
Market Cap Growth	-17.18%	-10.33%	-8.55%	4.95%	13.96%	16.31%
Enterprise Value	18,443	16,670	18,317	17,082	16,176	14,269
Last Close Price	24.11	24.94	27.70	29.49	38.00	33.26
PE Ratio	37.09	32.79	28.96	54.97	41.12	50.59
PS Ratio	1.66	1.85	2.05	3.43	3.66	3.36
PB Ratio	1.74	2.38	2.70	3.11	8.56	8.32
P/FCF Ratio	16.06	19.86	19.36	28.53	24.86	22.51
P/OCF Ratio	12.13	14.85	14.97	21.26	19.21	17.17
EV/Sales Ratio	2.43	2.45	2.68	3.82	4.04	3.73
EV/EBITDA Ratio	13.98	13.42	13.67	18.95	20.60	20.22
EV/EBIT Ratio	20.43	19.81	19.59	28.93	31.60	34.49
EV/FCF Ratio	23.59	26.26	25.23	31.72	27.46	25.00
Debt / Equity Ratio	1.16	0.98	1.17	1.34	1.56	2.78
Debt / EBITDA Ratio	5.60	3.71	4.08	6.41	2.99	5.28
Debt / FCF Ratio	10.45	8.17	8.39	12.24	4.52	7.52
Asset Turnover	0.44	0.50	0.47	0.46	0.60	0.57
Inventory Turnover	4.04	4.02	4.42	4.19	4.46	4.95
Quick Ratio	0.88	0.72	0.97	1.07	0.87	0.99
Current Ratio	1.12	0.81	1.05	1.14	0.97	1.05
Return on Equity (ROE)	5.13%	7.38%	9.31%	8.65%	21.97%	17.44%
Return on Assets (ROA)	3.23%	3.87%	3.98%	3.77%	4.77%	3.85%
Return on Capital (ROIC)	4.05%	4.87%	4.98%	4.78%	6.30%	5.03%
Return on Capital Employed (ROCE)	6.00%	8.40%	8.60%	5.40%	12.90%	10.50%
Earnings Yield	2.70%	3.05%	3.45%	1.82%	2.43%	1.98%
FCF Yield	6.23%	5.04%	5.17%	3.50%	4.02%	4.44%
Dividend Yield	2.11%	0.46%	0.40%	0.31%	0.23%	0.22%
Payout Ratio	393.67%	74.59%	52.76%	52.59%	52.85%	-
Buyback Yield / Dilution	-0.36%	-0.04%	-25.47%	-7.93%	-0.16%	-0.13%
Total Shareholder Return	1.76%	0.42%	-25.07%	-7.62%	0.07%	0.09%

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q